The AFSUMB consensus statements and recommendations for the clinical practice of contrast-enhanced ultrasound using sonazoid
Open Access
- 1 January 2020
- journal article
- research article
- Published by Medknow in Journal of Medical Ultrasound
- Vol. 28 (2) , 59-82
Abstract
The first edition of the guidelines for the use of ultrasound contrast agents was published in 2004, dealing with liver applications. The second edition of the guidelines in 2008 reflected changes in the available contrast agents and updated the guidelines for the liver, as well as implementing some nonliver applications. The third edition of the contrast-enhanced ultrasound (CEUS) guidelines was the joint World Federation for Ultrasound in Medicine and Biology-European Federation of Societies for Ultrasound in Medicine and Biology (WFUMB-EFSUMB) venture in conjunction with other regional US societies such as Asian Federation of Societies for Ultrasound in Medicine and Biology, resulting in a simultaneous duplicate on liver CEUS in the official journals of both WFUMB and EFSUMB in 2013. However, no guidelines were described mainly for Sonazoid due to limited clinical experience only in Japan and Korea. The new proposed consensus statements and recommendations provide general advice on the use of Sonazoid and are intended to create standard protocols for the use and administration of Sonazoid in hepatic and pancreatobiliary applications in Asian patients and to improve patient management.Keywords
This publication has 106 references indexed in Scilit:
- Contrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseasesBritish Journal of Radiology, 2012
- Usefulness of Contrast-Enhanced Intraoperative Ultrasound Using Sonazoid in Patients With Hepatocellular CarcinomaAnnals of Surgery, 2011
- Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: comparison with dynamic CTBritish Journal of Radiology, 2011
- Arterial-phase contrast-enhanced ultrasonography for evaluating anti-angiogenesis treatment: A pilot studyWorld Journal of Gastroenterology, 2011
- Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinomaWorld Journal of Gastroenterology, 2011
- Hepatic malignancies: Correlation between sonographic findings and pathological featuresWorld Journal of Radiology, 2010
- Contrast enhanced ultrasound of hepatocellular carcinomaWorld Journal of Radiology, 2010
- Contrast-enhanced harmonic ultrasound imaging in ablation therapy for primary hepatocellular carcinomaWorld Journal of Radiology, 2009
- Going from evidence to recommendationsBMJ, 2008
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000